MPP 89Homo sapiens (Human)Cancer cell line

Also known as: MPP89, MPP-89

🤖 AI SummaryBased on 5 publications

Quick Overview

Human cell line for cancer research, unknown tissue and disease

Detailed Summary

MPP 89 is a human cell line with unknown tissue and disease origins. It is used in cancer research, though specific applications are not detailed in the provided data. The cell line's characteristics, including its genetic and molecular properties, are not fully described, and further research is needed to determine its potential uses in biomedical studies. The lack of detailed information on its origin and specific applications highlights the need for additional characterization to support its utility in scientific investigations.
Generated on 6/17/2025

Basic Information

Database IDCVCL_1427
SpeciesHomo sapiens (Human)
Tissue SourcePleural effusion[UBERON:UBERON_0000175]

Donor Information

Age67
Age CategoryAdult
SexMale

Disease Information

DiseasePleural mesothelioma
LineagePleura
SubtypePleural Mesothelioma, Epithelioid Type
OncoTree CodePLEMESO

DepMap Information

Source TypeICLC
Source IDACH-000319_source

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
11,12
D13S317
13
D16S539
11,13
D5S818
11,12
D7S820
11,12
TH01
8
TPOX
8
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis.

Mutti L.

Eur. Respir. J. 13:527-534(1999).